XAIR insider trading
NasdaqCM HealthcareBeyond Air, Inc. — scored insider trade history from SEC Form 4 filings, parsed and contextualised by FilingIQ.
About Beyond Air, Inc.
Beyond Air, Inc., a commercial-stage medical device and biopharmaceutical company, develops the Lungfit platform, a nitric oxide (NO) generator and delivery system platform. It operates through three segments: Beyond Air, Beyond Cancer, and NeuroNos. The company offers Lungfit PH for the treatment of persistent pulmonary hypertension of the newborn. It is also developing LungFit PRO for the treatment of viral lung infections, such as community-acquired pneumonia, including COVID-19 and bronchiolitis in hospitalized patients; and LungFit GO for the treatment of nontuberculous mycobacteria (NTM) at home. In addition, the company develops ultra-high concentration (UNO) that is in Phase 1 clinical trial to treat multiple solid and cutaneous tumors; and selective neuronal nitric oxide synthase (nNOS) inhibitor for the treatment of neurological conditions and autism spectrum disorder. It has a collaboration with the Yissum Research Development Company of the Hebrew University of Jerusalem, LTD to acquire the commercial rights for neuronal nitric oxide synthase inhibitors to treat autism spectrum disorder and other neurological conditions. The company was formerly known as AIT Therapeutics, Inc. and changed its name to Beyond Air, Inc. in June 2019. Beyond Air, Inc. was founded in 2011 and is headquartered in Garden City, New York.
Company website: www.beyondair.net
XAIR insider activity at a glance
FilingIQ has scored 286 insider transactions for XAIR since Jun 3, 2019. The most recent filing in our index is dated Jan 5, 2026.
Across the full history, 85 open-market purchases
and 61 open-market sales
were filed under transaction codes P and S respectively. Compensatory share awards
(code A) and option exercises (code M) are tracked separately and not counted here.
The average FilingIQ composite score on XAIR insider trades is 60.7/100, produced by FilingIQ's multi-factor Form 4 model. Model framework documented at methodology.
Latest XAIR Form 4 filings
Most recent disclosures. Sign up to filter by score, transaction code, or insider role.
Other Healthcare tickers with recent insider activity
Frequently asked
- How many insider trades does FilingIQ track for XAIR?
- FilingIQ tracks 286 Form 4 insider transactions for XAIR (Beyond Air, Inc.), covering filings from Jun 3, 2019 onwards. 0 of those were filed in the last 90 days.
- Are XAIR insiders net buyers or net sellers?
- Across the full Form 4 history for XAIR, 85 transactions (30%) were open-market purchases and 61 (21%) were open-market sales. Compensatory awards and option exercises are filtered out of these counts.
- Where does XAIR insider data come from?
- Every transaction shown on this page is sourced directly from SEC EDGAR Form 4 filings. FilingIQ parses the raw XML, normalises insider identity across reporting variations, and scores each trade on its multi-factor composite model.
- What sector is XAIR in?
- Beyond Air, Inc. (XAIR) is classified in the Healthcare sector, specifically Medical Devices, with a current market capitalisation of $7.27M.
Methodology & sources
Every XAIR insider transaction shown on FilingIQ is parsed directly from a public SEC Form 4 XML filing. Insider identity is normalised across reporting variants (CIK changes, name spellings, related-party indirect holdings). The FilingIQ composite score is documented in full on the team page and algo disclosure. Not investment advice; see disclaimer.